Fingerprint
Dive into the research topics of 'The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy
Sabrina Giacoppo, Maria Ruscica, Luigi Maria Grimaldi, Placido Bramanti, Emanuela Mazzon
Research output: Contribution to journal › Article › peer-review